Business Wire

NEUSTAR

16.9.2020 09:32:11 CEST | Business Wire | Press release

Share
DDoS Attacks Increase by 151% in First Half Of 2020

Neustar, Inc. , a global information services and technology company and leader in identity resolution, today released its latest cyberthreats and trends report which identifies significant shifts in distributed denial-of-service (DDoS) attack patterns in the first half of 2020. Neustar’s Security Operations Centre (SOC) saw a 151% increase in the number of DDoS attacks compared to the same period in 2019. These included the largest and longest attacks that Neustar has ever mitigated at 1.17 Terabits-per-second (Tbps) and 5 days and 18 hours respectively. These figures are representative of the growing number, volume and intensity of network-type cyberattacks as organisations shifted to remote operations and workers’ reliance on the internet increased.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200916005046/en/

Neustar’s role in providing navigation for internet requests (via its global UltraDNS network) and in detecting and mitigating threats (through its UltraDDoS Protect service) has given the company a front-row seat from which to observe macro cyberattack trends, as detailed in its CyberThreats and Trends Report: Jan-Jun 2020.

Largest and smallest DDoS attacks becoming increasingly intense and sophisticated

Large DDoS attacks are bigger, more intense, and happening in greater numbers than ever before. There has been a noticeable spike in large attacks across the industry, most notably the 2.3 Tbps attack targeting an Amazon Web Services client in February – the largest volumetric DDoS attack on record.

Neustar saw the total number of attacks increase by over two and a half times during January through June of 2020 compared to the same period in 2019. The increase was felt across all size categories, with the biggest growth happening at opposite ends of the scale – the number of attacks sized 100 Gbps and above grew a whopping 275% and the number of very small attacks, sized 5 Gbps and below, increased by more than 200%. Overall, small attacks sized 5 Gbps and below represented 70% of all attacks mitigated by Neustar between January and June of 2020.

“While large volumetric attacks capture attention and headlines, bad actors increasingly recognise the value of striking at low enough volume to bypass the traffic thresholds that would trigger mitigation to degrade performance or precision target vulnerable infrastructure like a VPN,” said Michael Kaczmarek, Neustar Vice President of Security Products. “These shifts put every organisation with an internet presence at risk of a DDoS attack – a threat that is particularly critical with global workforces reliant on VPNs for remote login. VPN servers are often left vulnerable, making it simple for cybercriminals to take an entire workforce offline with a targeted DDoS attack."

The rise in smaller DDoS attacks has been matched by increases in attack sophistication and intensity. 52% of threats mitigated by Neustar leveraged three vectors or more, with the number of attacks featuring a single vector essentially nonexistent. Neustar also tracked new amplification methods and attacks of higher intensity targeted at critical pieces of web infrastructure. The previous high-water mark of 500 millions-of-packets-per-second (Mpps) was topped this year, with an attack of over 800 Mpps recorded.

“The dependency and growth in online communications since COVID-19 has fundamentally changed what organisations must do to succeed,” said Brian McCann, President, Neustar Security Solutions. “There is no one-size-fits-all solution for security, but having a reliable cloud service that ensures availability and security for all services and users has proven to be a critical difference between barely surviving and thriving in this rapidly changing environment.”

Ongoing impact of COVID-19 on cyberthreats and industry web traffic

The precipitous rise in DDoS attacks mirrors the growth in internet traffic seen during the pandemic. Internet use is up between 50% and 70% and streaming media rose more than 12% in the first quarter of 2020 . This has meant that attackers of all types, whether serious cybercriminals or bored teenagers stuck at home, have had more screen time to be disruptive.

In a study of one of the largest cybercrime sites by Cambridge University’s Cybercrime Centre , they found that the number of attacks enacted by the website went up sharply at the start of the pandemic and associated lockdown. They also found that instead of existing cybercriminals staging more attacks, it was new attackers driving the increase in DDoS attacks.

The corresponding attacks, like internet traffic, have not been evenly spread across all websites. It’s well known that ecommerce and gaming websites have received a lot of negative attention from hackers, but there are other industries that have been hit hard by cybercriminals over the last six months. Healthcare organisations contain sensitive patient information and a growing number of IoT devices that are easily exploited. Combined with the additional pressure of the pandemic, hospitals have become some of the most desirable targets for cybercriminals. Industries that have seen a lot of growth during the pandemic, like online gambling, have also been ripe for cyberthreats. Most notably, online video has seen an incredible rise in both usage and DDoS attacks. Omdia has reported an additional 200 billion hours of Netflix viewing or Zoom video calls over initial 2020 forecasts. Where traffic rises, so too do attacks; Neustar attack mitigations for this vertical increased by 461% over the last six months.

“While 2020 has brought radical changes in behaviour to consumers and criminals alike, it is naïve to assume that actions of either audience will revert completely to pre-pandemic norms after this crisis passes,” added Kaczmarek. “Mitigating these increasingly sophisticated DDoS attacks will continue to be a necessary part of doing business online. At a time when many organisations could do with less worry, fully managed services can take the pressure off and ensure critical digital assets are safe and secure.”

The report highlights several emerging attacker tactics seen across the industry, including an increase in burst and pulse DDoS attacks, broadening abuse of built-in network protocols such as ARMS, WS-DD, CoAP and Jenkins to launch DDoS amplification attacks that can be carried out with limited resources and cause significant disruptions, NXNS attacks targeting DNS servers, RangeAmp attacks targeting Content Delivery Networks (CDNs), and a resurgence of Marai-like malware capable of building large botnets through the exploitation of poorly secured IoT devices.

A complimentary copy of Neustar’s CyberThreats and Trends Report 1H 2020 is available here .

-ENDS-

About Neustar

Neustar is an information services and technology company and a leader in identity resolution providing the data and technology that enables trusted connections between companies and people at the moments that matter most. Neustar offers industry-leading solutions in Marketing, Risk, Communications and Security that responsibly connect data on people, devices and locations, continuously corroborated through billions of transactions. Neustar serves more than 8,000 clients worldwide, including 60 of the Fortune 100. Learn how your company can benefit from the power of trusted connections here: https://www.home.neustar .

# # #

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release

- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release

Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release

Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye